Prolacta Bioscience®, the pioneer in human milk-based neonatal nutritional products for premature infants, announced today that a new analysis, published in the journal Breastfeeding Medicine, found additional clinically significant benefits of an exclusive human milk diet (EHMD) for extremely premature infants in the neonatal intensive care unit (NICU), when compared to a diet containing cow milk-based products.
Results from the analysis, “Beyond Necrotizing Enterocolitis: Other Clinical Advantages of an Exclusive Human Milk Diet,” showed that infants fed an EHMD required significantly fewer days of parenteral (intravenous) nutrition (PN) and attained full enteral feeds significantly sooner than infants fed a diet containing cow milk-based fortifier or cow milk-based formula. The analysis also found a trend toward fewer days of ventilator support for infants on an EHMD. Using standard analytical techniques to combine data from two previously published clinical trials, the researchers examined the effect of varying amounts of cow milk-based products on specific interventions.
They found that the number of PN days and the time to full feeds increased as the amount of cow milk-based nutrition in the premature infants’ diets increased, suggesting a dose-response relationship. Taken together, these analyses point to results that could potentially lead to substantially reduced costs of care for infants on an EHMD. “We are only beginning to unlock the full potential of an exclusive human milk diet in extremely premature infants,” said Amy Hair, M.D., first author of the paper.
“This data underscores the clinical and cost consequences of using cow milk nutrition in the NICU.” Dr. Hair is a neonatologist and an assistant professor of pediatrics at Baylor College of Medicine, and the director of the Neonatal Nutrition Program at Texas Children’s Hospital in Houston, Texas. The analysis included 260 extremely premature infants born weighing less than 1250 g (2 lb 12 oz) at birth, who were evaluated in the two previous studies.
Infants were randomly assigned to receive an EHMD, including mother’s own milk or donor human milk and Prolacta’s Prolact+ H2MF® Human Milk-Based Human Milk Fortifier, or a diet of mother’s own milk with cow milk-based fortifier, or formula. The research examined any relationships between the volume of cow milk nutrition in each infant’s diet and the number of days they received common interventions in the NICU, including PN and the number of days until full enteral feeds were achieved. The number of days that a central line, ventilator support and oxygen supplementation were used were also evaluated.